Validation of the Partin Nomogram for Prostate Cancer in a National Sample

被引:49
|
作者
Yu, James B. [1 ]
Makarov, Danil V. [3 ,5 ]
Sharma, Richa [4 ]
Peschel, Richard E. [1 ]
Partin, Alan W. [6 ]
Gross, Cary P. [2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Sch Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[5] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA
[6] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
关键词
prostate; prostatic neoplasms; neoplasm staging; nomograms; SEER program; PREDICT PATHOLOGICAL STAGE; RADICAL PROSTATECTOMY; CLINICAL STAGE; GLEASON SCORE; EXTERNAL VALIDATION; RADIATION-THERAPY; TABLES; ANTIGEN; MEN; ADENOCARCINOMA;
D O I
10.1016/j.juro.2009.08.143
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The Partin tables are a nomogram that is widely used to discriminate prostate cancer pathological stages, given common preoperative clinical characteristics. The nomogram is based on patients undergoing radical prostatectomy at The Johns Hopkins Medical Institutions. We validated the Partin tables in a large, population based sample. Materials and Methods: The National Cancer Institute Surveillance, Epidemiology and End Results database was used to identify patients treated from 2004 to 2005 who underwent radical prostatectomy. The 2007 Partin tables were used to estimate the prevalence of positive lymph nodes, seminal vesicle invasion, extraprostatic extension and organ confined disease in men with prostate cancer in the database using clinical stage, preoperative prostate specific antigen and Gleason score. The discriminative ability of the tables was explored by constructing ROC curves. Results: We identified 11,185 men who underwent radical prostatectomy for prostate cancer in 2004 to 2005. The Partin tables discriminated well between patient groups at risk for positive lymph nodes and seminal vesicle invasion (AUC 0.77 and 0.74, respectively). The discrimination of extraprostatic extension and organ confined disease was more limited (AUC 0.62 and 0.68, respectively). The AUC for positive lymph nodes was 0.78 in white men, 0.73 in black men and 0.83 in Asian/Pacific Islander men (p = 0.17). The AUC for positive lymph nodes in men 61 years old or younger was 0.80 vs 0.74 in men older than 61 years (p 0.03). Conclusions: The Partin tables showed excellent discrimination for seminal vesicle invasion and positive lymph nodes. Discrimination of extraprostatic extension and organ confined disease was more limited. The Partin tables performed best in young men.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 50 条
  • [41] Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy
    Lughezzani, Giovanni
    Lazzeri, Massimo
    Haese, Alexander
    McNicholas, Thomas
    de la Taille, Alexandre
    Buffi, Nicolo Maria
    Fossati, Nicola
    Lista, Giuliana
    Larcher, Alessandro
    Abrate, Alberto
    Mistretta, Alessandro
    Bini, Vittorio
    Redorta, Joan Palou
    Graefen, Markus
    Guazzoni, Giorgio
    EUROPEAN UROLOGY, 2014, 66 (05) : 906 - 912
  • [42] Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer
    Zamboglou, Constantinos
    Peeken, Jan C.
    Janbain, Ali
    Katsahian, Sandrine
    Strouthos, Iosif
    Ferentinos, Konstantinos
    Farolfi, Andrea
    Koerber, Stefan A.
    Debus, Juergen
    Vogel, Marco E.
    Combs, Stephanie E.
    Vrachimis, Alexis
    Morganti, Alessio Giuseppe
    Spohn, Simon K. B.
    Shelan, Mohamed
    Aebersold, Daniel M.
    Grosu, Anca-Ligia
    Ceci, Francesco
    Henkenberens, Christoph
    Kroeze, Stephanie G. C.
    Guckenberger, Matthias
    Fanti, Stefano
    Belka, Claus
    Bartenstein, Peter
    Hruby, George
    Scharl, Sophia
    Wiegel, Thomas
    Emmett, Louise
    Arnoux, Armelle
    Schmidt-Hegemann, Nina-Sophie
    JAMA NETWORK OPEN, 2023, 6 (05)
  • [43] A Modified Partin Table to Better Predict Extracapsular Extension in Clinically Localized Prostate Cancer
    Merder, Erkan
    Ariman, Ahmet
    Altunrende, Fatih
    UROLOGY JOURNAL, 2021, 18 (01) : 74 - 80
  • [44] Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram
    Kutikov, A.
    Cooperberg, M. R.
    Paciorek, A. T.
    Uzzo, R. G.
    Carroll, P. R.
    Boorjian, S. A.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (04) : 374 - 379
  • [45] Development and external validation of a prostate health index-based nomogram for predicting prostate cancer
    Zhu, Yao
    Han, Cheng-Tao
    Zhang, Gui-Ming
    Liu, Fang
    Ding, Qiang
    Xu, Jian-Feng
    Vidal, Adriana C.
    Freedland, Stephen J.
    Ng, Chi-Fai
    Ye, Ding-Wei
    SCIENTIFIC REPORTS, 2015, 5
  • [46] Prospective validation of a nomogram predictive of a positive initial prostate biopsy
    Ramirez-Backhaus, M.
    Bahilo, P.
    Arlandis, S.
    Santamaria Navarro, C.
    Pontones Moreno, J. L.
    Jimenez-Cruz, F.
    ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (01): : 35 - 42
  • [47] External validation of the updated partin tables in a cohort of North American men
    Karakiewicz, Pierre I.
    Bhojani, Naeem
    Capitanio, Umberto
    Reuther, Alwyn M.
    Suardi, Nazareno
    Jeldres, Claudio
    Pharand, Daniel
    Peloquin, Francois
    Perrotte, Paul
    Shariat, Shahrokh F.
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2008, 180 (03) : 898 - 902
  • [48] Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
    Hansen, Jens
    Auprich, Marco
    Ahyai, Sascha A.
    de la Taille, Alexandre
    van Poppel, Hendrik
    Marberger, Michael
    Stenzl, Arnulf
    Mulders, Peter F. A.
    Huland, Hartwig
    Fisch, Margit
    Abbou, Clement-Claude
    Schalken, Jack A.
    Fradet, Yves
    Marks, Leonard S.
    Ellis, William
    Partin, Alan W.
    Pummer, Karl
    Graefen, Markus
    Haese, Alexander
    Walz, Jochen
    Briganti, Alberto
    Shariat, Shahrokh F.
    Chun, Felix K.
    EUROPEAN UROLOGY, 2013, 63 (02) : 201 - 209
  • [49] Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
    Wu, Qiang
    Li, Fanglong
    Yin, Xiaotao
    Gao, Jiangping
    Zhang, Xu
    MEDICINE, 2021, 100 (50) : E28196
  • [50] A nomogram to predict Gleason sum upgrading of clinically diagnosed localized prostate cancer among Chinese patients
    Wang, Jin-You
    Zhu, Yao
    Wang, Chao-Fu
    Zhang, Shi-Lin
    Dai, Bo
    Ye, Ding-Wei
    CHINESE JOURNAL OF CANCER, 2014, 33 (05) : 241 - 248